Navigation Links
Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23

his cautionary statement and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

    CONTACTS:

    OREXIGEN                    MEDIA                    INVESTORS

    Graham Cooper               Stephen Gendel           Jason Spark

    858 436-8600                212 918-4650             619 849-6005

CONTACT: Graham Cooper, +1-858-436-8600, Stephen Gendel, +1-212-918-4650Jason Spark, +1-619-849-6005, all for Orexigen(TM) Therapeutics, Inc.

Web site: http://www.Orexigen.com/

Ticker Symbol: (NASDAQ-NMS:OREX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
9. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
10. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
11. Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis

Post Your Comments:
(Date:11/25/2009)...DIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(...opingproductsforminimallydisruptivesurgicaltreatme...encecallonMonday,November30,2009,at5:30p.m.ET/2:30...lativetoreimbursementfortheCompany,sproductsandwil...tionandanswersession.Thedial-innumbersare1-877-407...
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...ISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagn...oviderofdiagnostictesting,informationandservices,a...erJaffrayHealthcareConferenceinNewYorkCity.Thepres...30a.m.EasternTime. ,, Duringtheconference,theco...approximate3%,operatingincometoexceed18%ofrevenues...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 1EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 2Rare Cells Linked to Pediatric Cancers 51764 1Rare Cells Linked to Pediatric Cancers 51764 2Stem Cell Decision Opens New Doors May Spur More Research 51762 1Stem Cell Decision Opens New Doors May Spur More Research 51762 2Stem Cell Decision Opens New Doors May Spur More Research 51762 3
...dy to Indicate that Early Use of Estrogen May be,C...re-USNewswire/ -- A new analysis,of Women,s Health...nal of Medicine, shows significant reduction in ca...ne therapy (HT) compared,with women taking a place...n estrogen therapy and coronary artery calcium,(CA...
...NDS, Texas--(BUSINESS WIRE)--Jun 21, 2007 - Opexa,...ed in the,development and commercialization of cel...a in an open-label Phase I/II,extension clinical t...n(TM), for multiple sclerosis (MS). In this one-ye...g remitting (RRMS),and secondary progressive (SPMS...
Other Medicine Technology:Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 2Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5
(Date:11/25/2009)...o signaling pathways essential to normal human dev...owth factor receptor (EGFR) pathways - interact in...astasis, researchers from The University of Texas ... issue of Molecular Cell . , This newly charact...ents known to correlate with invasive cancer - act...
(Date:11/25/2009)...ov. 25, 2009) Melvin R. Kaplan, MD, FACP, a forme...rch institute that became Los Angeles Biomedical R...A BioMed), will be honored by the American College...re of patients. , At its April 22, 2010 meeting ...l present Dr. Kaplan with the Ralph O. Claypoole S...
(Date:11/25/2009)...5, 2009 Physicians at UT Southwestern Medical Cen...ed to improve breathing in patients with upper spi... from breathing independently. , UT Southwester...y two sites in Texas and one of 25 in the country ...he NeuRx Diaphragm Pacing System. , The device i...
(Date:11/25/2009)...tify role mitochondrial function plays in insulin ...hDay News) -- Mitochondrial damage causes people w...s, a finding that could lead to new treatments, U....gy for cellular activity. , The researchers fou...ancreas can,t respond to circulating insulin, it t...
(Date:11/25/2009)... PCU College teaches students to use natu... , Burnaby, BC (Vocus) No... radiation are the standard, effective treatments ...o alternative medicine to help them cope with the ...creased number of cancer patients using acupunctur...
Breaking Medicine News(10 mins):Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Holistic and Western Medicine Combined Can Fight Cancer 2
... Kreager, Director of,Clinical Quality and Standar... Group, Inc. (LTCG), has been elected President of...he Long Term Care International Forum,( http://www...e industry., (Logo: http://www.newscom.com/cgi-b...
...lobal Health,innovator IntraHealth International w...ew five-year contract to improve public health nee...project was awarded to Washington,DC-based Chemoni...Project aims to improve the,health status of Pales...
...chers at UT Southwestern Medical Center have uncov...e" nature of a protein that stimulates stem-cell m...o lead to nerve-cell damage. , In two separate s... research teams studied the protein Cdk5 and disco...
...onal Primate Research Center, Emory University, ha... growth and generation of several types of neural ...October issue of the journal Stem Cells , suggest...tem. , Dental stem cells are adult stem cells, on...
...ice partners with AMICAS for growth and ...AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiolog...utions, today announced a new partnership with Ark...uctivity and,achieve this practice,s growth initia...
...1 To support,manufacturers developing affordable,...) (NYSE: TXN ) today introduced a family of fully... TX734, the first device in the TX7xx,family, is a...duces board space by 50 percent compared to discre...
Other Medicine News:Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2Health News:IntraHealth to Support Health Reform in Palestine 2Health News:Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find 2Health News:Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find 3Health News:Radiology Associates, P.A. Chooses AMICAS 2Health News:Radiology Associates, P.A. Chooses AMICAS 3Health News:Video: Ultrasound Systems Can Produce Clearer Images With TI's New Family of Fully Integrated High-Voltage Pulsers and Switches 2Health News:Video: Ultrasound Systems Can Produce Clearer Images With TI's New Family of Fully Integrated High-Voltage Pulsers and Switches 3Health News:Video: Ultrasound Systems Can Produce Clearer Images With TI's New Family of Fully Integrated High-Voltage Pulsers and Switches 4
Richardson Retractor
Smooth Round Moderate Plus Profile Breast Implant
Advanta™ ePTFE facial implants
Chin Implants
Medicine Products: